CF
ARNA

Centaurus Financial’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Centaurus Financial’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-205
Closed -$9K – 2241
2018
Q2 		$9K Buy
+205
New +$8.81K ﹤0.01% 1607

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Centaurus Financial's ARNA Position: Q3 2018 in Review

Centaurus Financial sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2018, closing a stake of 205 shares — an estimated $9K sold.

Centaurus Financial first reported a position in ARNA in Q2 2018 and held it in 1 quarter. The position peaked at $9K in Q2 2018. 160 funds tracked by Wall St. Rank hold ARNA as of Q3 2018.

  • Centaurus Financial reported no remaining Arena Pharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
  • Centaurus Financial sold 205 Arena Pharmaceuticals Inc shares in Q3 2018, an estimated $9K.
  • Centaurus Financial first reported a position in Arena Pharmaceuticals Inc in Q2 2018 and held it in 1 quarter.
  • Centaurus Financial's Arena Pharmaceuticals Inc position peaked at $9K in Q2 2018.
  • 160 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.